<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2498808-A4" country="EP" doc-number="2498808" kind="A4" date="20140108" family-id="43992418" file-reference-id="316600" date-produced="20180825" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146616217" ucid="EP-2498808-A4"><document-id><country>EP</country><doc-number>2498808</doc-number><kind>A4</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-10830785-A" is-representative="NO"><document-id mxw-id="PAPP154890544" load-source="docdb" format="epo"><country>EP</country><doc-number>10830785</doc-number><kind>A</kind><date>20101112</date><lang>EN</lang></document-id><document-id mxw-id="PAPP202945475" load-source="docdb" format="original"><country>EP</country><doc-number>10830785.1</doc-number><date>20101112</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140551874" ucid="US-2010056534-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>2010056534</doc-number><kind>W</kind><date>20101112</date></document-id></priority-claim><priority-claim mxw-id="PPC140548463" ucid="US-26027709-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>26027709</doc-number><kind>P</kind><date>20091111</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL-1620478417" load-source="docdb">A61K  39/00        20060101A I20180629RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989623532" load-source="docdb">C07K  19/00        20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989624483" load-source="docdb">C07H  21/00        20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989633951" load-source="docdb">A61K  39/02        20060101AFI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989636181" load-source="docdb">A61P  35/00        20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989646704" load-source="docdb">A61P  37/04        20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989651028" load-source="docdb">C12N   1/21        20060101ALI20131129BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2117109046" load-source="docdb" scheme="CPC">A61K  39/0011      20130101 FI20150113BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2117110558" load-source="docdb" scheme="CPC">A61K2039/523       20130101 LA20150113BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2117111517" load-source="docdb" scheme="CPC">A61K2039/522       20130101 LA20150113BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132405903" lang="DE" load-source="docdb">ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERHINDERUNG VON FLUCHTMUTATIONEN BEI DER BEHANDLUNG VON TUMOREN MIT HER2/NEU-ÜBEREXPRESSION</invention-title><invention-title mxw-id="PT132405904" lang="EN" load-source="docdb">COMPOSITIONS AND METHODS FOR PREVENTION OF ESCAPE MUTATION IN THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS</invention-title><invention-title mxw-id="PT132405905" lang="FR" load-source="docdb">COMPOSITIONS ET MÉTHODES DE PRÉVENTION DE MUTATION D'ÉCHAPPEMENT DANS LE TRAITEMENT DES TUMEURS SUREXPRIMANT HER2/NEU</invention-title><citations><patent-citations><patcit mxw-id="PCIT345602516" load-source="docdb" ucid="US-20090202587-A1"><document-id format="epo"><country>US</country><doc-number>20090202587</doc-number><kind>A1</kind><date>20090813</date></document-id><sources><source name="SEA" category="A" created-by-npl="N"/></sources></patcit></patent-citations><non-patent-citations><nplcit><text>CLIFTON GUY T ET AL: "Overcoming cancer immune tolerance and escape.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 FEB 2009, vol. 15, no. 3, 1 February 2009 (2009-02-01), pages 749 - 751, XP002717038, ISSN: 1078-0432</text><sources><source mxw-id="PNPL60027806" load-source="docdb" name="SEA" category="X"/></sources></nplcit><nplcit><text>GUNN G R ET AL: "Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 167, no. 11, 1 December 2001 (2001-12-01), pages 6471 - 6479, XP002289027, ISSN: 0022-1767</text><sources><source mxw-id="PNPL60027807" load-source="docdb" name="SEA" category="A"/></sources></nplcit><nplcit><text>SHAHABI V ET AL: "Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human", CANCER GENE THERAPY, vol. 18, no. 1, 20 August 2010 (2010-08-20), pages 53 - 62, XP002717040, ISSN: 0929-1903</text><sources><source mxw-id="PNPL60027808" load-source="docdb" name="SEA" category="XP"/></sources></nplcit><nplcit><text>SINGH RESHMA ET AL: "Fusion to listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 175, no. 6, 1 September 2005 (2005-09-01), pages 3663 - 3673, XP002461281, ISSN: 0022-1767</text><sources><source mxw-id="PNPL60027809" load-source="docdb" name="SEA" category="XY"/></sources></nplcit><nplcit><text>VAFA SHAHABI ET AL: "Development of a Listeria monocytogenes based vaccine against prostate cancer", CANCER IMMUNOLOGY, IMMUNOTHERAPY, SPRINGER, BERLIN, DE, vol. 57, no. 9, 14 February 2008 (2008-02-14), pages 1301 - 1313, XP019624387, ISSN: 1432-0851</text><sources><source mxw-id="PNPL60027810" load-source="docdb" name="SEA" category="Y"/></sources></nplcit><nplcit><text>VERCH THORSTEN ET AL: "Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 72, no. 11, 1 November 2004 (2004-11-01), pages 6418 - 6425, XP002508995, ISSN: 0019-9567, DOI: 10.1128/IAI.72.11.6418-6425.2004</text><sources><source mxw-id="PNPL60027811" load-source="docdb" name="SEA" category="A"/></sources></nplcit><nplcit><text>WALLECHA ANU ET AL: "Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics", ADVANCES IN APPLIED MICROBIOLOGY, ACADEMIC PRESS, UNITED STATES, vol. 66, 1 January 2009 (2009-01-01), pages 1 - 27, XP009160710, ISSN: 0065-2164</text><sources><source mxw-id="PNPL60027812" load-source="docdb" name="SEA" category="A"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR919542670" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ADVAXIS</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR919510836" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ADVAXIS</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919508296" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SHAHABI VAFA</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919532308" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SHAHABI, VAFA</last-name></addressbook></inventor></inventors></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS549928515" load-source="docdb">AL</country><country mxw-id="DS549796553" load-source="docdb">AT</country><country mxw-id="DS549928516" load-source="docdb">BE</country><country mxw-id="DS549904136" load-source="docdb">BG</country><country mxw-id="DS549893428" load-source="docdb">CH</country><country mxw-id="DS549809270" load-source="docdb">CY</country><country mxw-id="DS549809271" load-source="docdb">CZ</country><country mxw-id="DS549896714" load-source="docdb">DE</country><country mxw-id="DS549928517" load-source="docdb">DK</country><country mxw-id="DS549928518" load-source="docdb">EE</country><country mxw-id="DS549882104" load-source="docdb">ES</country><country mxw-id="DS549904137" load-source="docdb">FI</country><country mxw-id="DS549904138" load-source="docdb">FR</country><country mxw-id="DS549896715" load-source="docdb">GB</country><country mxw-id="DS549928519" load-source="docdb">GR</country><country mxw-id="DS549896716" load-source="docdb">HR</country><country mxw-id="DS549809272" load-source="docdb">HU</country><country mxw-id="DS549893433" load-source="docdb">IE</country><country mxw-id="DS549928520" load-source="docdb">IS</country><country mxw-id="DS549904139" load-source="docdb">IT</country><country mxw-id="DS549928521" load-source="docdb">LI</country><country mxw-id="DS549896721" load-source="docdb">LT</country><country mxw-id="DS549796554" load-source="docdb">LU</country><country mxw-id="DS549904140" load-source="docdb">LV</country><country mxw-id="DS549896722" load-source="docdb">MC</country><country mxw-id="DS549796555" load-source="docdb">MK</country><country mxw-id="DS549796556" load-source="docdb">MT</country><country mxw-id="DS549796565" load-source="docdb">NL</country><country mxw-id="DS549893434" load-source="docdb">NO</country><country mxw-id="DS549796566" load-source="docdb">PL</country><country mxw-id="DS549882105" load-source="docdb">PT</country><country mxw-id="DS549800731" load-source="docdb">RO</country><country mxw-id="DS549882110" load-source="docdb">RS</country><country mxw-id="DS549796567" load-source="docdb">SE</country><country mxw-id="DS549896723" load-source="docdb">SI</country><country mxw-id="DS549893435" load-source="docdb">SK</country><country mxw-id="DS549893436" load-source="docdb">SM</country><country mxw-id="DS549928522" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
